(DIR) Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
 (HTM) https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
 (DIR) Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 4089--------------------------------------------------
       Phase III trial:  Ocrevus twice yearly w/10-minute subcutaneous 
       injection
       By: agate Date: July 13, 2023, 1:52 pm
       ---------------------------------------------------------
       Maybe Ocrevus will be available as a twice-yearly 10-minute
       subcutaneous injection. It's not clear whether the injection can
       be self-administered but my guess is that the person with MS
       would need to go to a medical facility for the injection.
       From Business Wire   (July 13, 2023)--"Positive Phase III
       results for Genetech's Ocrevus (ocrelizumab) twice a  year,
       10-minute subcutaneous injection in patients with multiple
       sclerosis":
       
 (HTM) https://bit.ly/3DcjV7T
       #Post#: 4092--------------------------------------------------
       Positive results found for new Ocrevus subcutaneous formulation
       By: agate Date: July 15, 2023, 1:45 am
       ---------------------------------------------------------
       This article makes it clear that the 10-minute subcutaneous
       version of Ocrevus isn't meant to be self-administered. The
       patient would go to an MS center for the injections, presumably.
       From Multiple Sclerosis News Today (July 14, 2023)--"Positive
       results found for new Ocrevus under-the-skin formulation":
 (HTM) https://multiplesclerosisnewstoday.com/news-posts/2023/07/14/under-skin-ocrevus-formulation-ms-comparable-approved-therapy/
       #Post#: 4161--------------------------------------------------
       Subcutaneous Ocrevus similar to IV treatment for patients w/PPMS
        or RMS
       By: agate Date: September 20, 2023, 1:22 am
       ---------------------------------------------------------
       From Practical Neurology (July 23, 2023)--"Subcutaneous Ocrevus
       Similar to IV Treatment for Patients with PPMS or RMS":
 (HTM) https://tinyurl.com/3mrw4hb5
       #Post#: 4185--------------------------------------------------
       (ECTRIMS) New under-the-skin Ocrevus found effective in MS
       By: agate Date: October 12, 2023, 8:35 pm
       ---------------------------------------------------------
       From Multiple Sclerosis News Today (October 12, 2023)--"ECTRIMS
       2023: New under-the-skin Ocrevus found effective in MS":
 (HTM) https://bit.ly/3ZVf5Xb
       *****************************************************